Precision medicine. Informed care.
Did you know that over 4.3 billion prescriptions were filled last year in the U.S. alone, yet less than 50% were effective as prescribed? It’s time to do something about it — and we’re incredibly honored to help.
Russell Herder has been named agency of record for OneOme, a privately held company backed by Invenshure, LLC and co-developed and exclusively licensed from Mayo Clinic. We’re creatively and strategically helping introduce this industry-changing innovation to pharmacists, providers, health system administrators and consumers.
Driven to improve patient care and reduce overall healthcare costs, OneOme recently announced global availability of the RightMed™ pharmacogenomic (PGx) test. Across more than 340 medications for more than 20 medical indications, this cost-effective, comprehensive test helps healthcare providers easily make timely, evidenced-based, personalized prescription treatment decisions. OneOme is partnering with leading health systems across the U.S., Puerto Rico, Cuba, and the Dominican Republic.
The OneOme RightMed™ PGx test can be ordered by a provider through their online portal. OneOme will send the DNA prescription test kit — a simple cheek swab test — to the patient’s home. After the patient returns their sample in the pre-paid envelope and OneOme completes the analysis, the ordering provider will have access to a clear, actionable report through the portal.
Healthcare of the future. Available today. Watch for more from us about the OneOme story in the weeks and months to come. To learn more now, visit www.oneome.com.
Latest posts by Russell Herder (see all)
- Brand Matters: Rebranding Truths - March 24, 2017
- Why Media Visibility is More Important Than Ever Before - March 16, 2017
- RoyOMartin Names Russell Herder Agency of Record - March 9, 2017